{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:00:38Z","timestamp":1789750838785,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.cyto.2018.04.017","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T13:38:39Z","timestamp":1524404319000},"page":"18-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Association of interleukin-17A polymorphisms with the risk of colorectal cancer: A case-control study"],"prefix":"10.1016","volume":"110","author":[{"given":"Sinda A.","family":"Bedoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouadh","family":"Barbirou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Stayoussef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Dallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Mokrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Makni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Mezlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balkiss","family":"Bouhaouala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besma","family":"Yacoubi-Loueslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.04.017_b0005","first-page":"933","volume":"62","author":"Bardou","year":"2013","journal-title":"Obesity and colorectal cancer. Gut"},{"key":"10.1016\/j.cyto.2018.04.017_b0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cgh.2009.05.032","article-title":"Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis","volume":"7","author":"Heitman","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2018.04.017_b0015","unstructured":"A.M. Arfaoui Toumi, L.I. Kriaa Ben Mahmoud, L.I. Khiari, A.H. Lahmer, L.A. Gharbi, M.O. Dhra\u00efef, et al., \u00c9tude \u00e9pid\u00e9miologique, anatomopathologique et \u00e9valuation des facteurs pronostiques de l\u2019ad\u00e9nocarcinome colorectal mucineux vs non mucineux, La Tunisie M\u00e9dicale, 88 (2010) 12\u201317."},{"key":"10.1016\/j.cyto.2018.04.017_b0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","article-title":"Molecular basis for sunitinib efficacy and future clinical development","volume":"6","author":"Faivre","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cyto.2018.04.017_b0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00423-014-1176-8","article-title":"International quality assurance project in colorectal cancer-unifying diagnostic and histopathological evaluation","volume":"399","author":"Jannasch","year":"2014","journal-title":"Langenbecks Arch. Surg."},{"key":"10.1016\/j.cyto.2018.04.017_b0030","first-page":"169","article-title":"Tumor markers in colorectal cancer Cir","volume":"81","author":"Men\u00e9ndez-S\u00e1nchez","year":"2013","journal-title":"Cir."},{"key":"10.1016\/j.cyto.2018.04.017_b0035","first-page":"1295","article-title":"Microbiote et cancer colorectal: des bact\u00e9ries g\u00e9notoxiques dans le tractus intestinal","volume":"195","author":"Nougayr\u00e8de","year":"2011","journal-title":"Bull. Acad. Natl. M\u00e9d."},{"key":"10.1016\/j.cyto.2018.04.017_b0040","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/aje\/kws192","article-title":"Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort","volume":"176","author":"Renehan","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cyto.2018.04.017_b0045","first-page":"400","article-title":"Body mass index and screening for colorectal cancer: gender and attitudinal factors","volume":"36","author":"Messina","year":"2012","journal-title":"CancerEpidemiol."},{"key":"10.1016\/j.cyto.2018.04.017_b0050","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1007\/s13277-014-1890-4","article-title":"Significant association between interleukin-17A polymorphism and colorectal cancer","volume":"35","author":"Omrani","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cyto.2018.04.017_b0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.imlet.2014.01.002","article-title":"Significant association between IL23R and IL17F polymorphisms and clinical features of colorectal cancer","volume":"158","author":"Omrani","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2018.04.017_b0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.gene.2015.02.014","article-title":"Interleukin-17F T7488 allele is associated with a decreased risk of colorectal cancer and tumor progression","volume":"561","author":"Nemati","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.cyto.2018.04.017_b0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2018.04.017_b0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/gtc.12039","article-title":"Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells","volume":"18","author":"Kurebayashi","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.cyto.2018.04.017_b0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijc.25027","article-title":"Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer","volume":"127","author":"Wu","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2018.04.017_b0080","article-title":"X.L., Association between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population","volume":"15","author":"Zhao","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.cyto.2018.04.017_b0085","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2018.04.017_b0090","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/intimm\/dxh111","article-title":"Involvement of IL-17 in Fas ligand-induced inflammation","volume":"16","author":"Umemura","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2018.04.017_b0095","doi-asserted-by":"crossref","first-page":"436307","DOI":"10.1155\/2013\/436307","article-title":"Interleukin-17: a promoter in colorectal cancer progression","volume":"2013","author":"Wu","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cyto.2018.04.017_b0100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mc.21928","article-title":"Interleukin-17 gene polymorphisms are associated with bladder cancer in a Chinese Han population","volume":"52","author":"Zhou","year":"2012","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.cyto.2018.04.017_b0105","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s13277-013-1217-x","article-title":"Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.cyto.2018.04.017_b0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2011.03.021","article-title":"IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma","volume":"407","author":"Liu","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2018.04.017_b0115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2018.04.017_b0120","doi-asserted-by":"crossref","first-page":"e34400","DOI":"10.1371\/journal.pone.0034400","article-title":"Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2018.04.017_b0125","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s11033-013-2975-7","article-title":"Association between polymorphisms in the interleukin 10 promoter region and susceptibility to inflammatory bowel disease","volume":"41","author":"Lv","year":"2014","journal-title":"Mol. Bio. Rep."},{"key":"10.1016\/j.cyto.2018.04.017_b0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2012.09.009","article-title":"Interleukin-10-1082A\/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects","volume":"61","author":"Zhu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.04.017_b0135","doi-asserted-by":"crossref","first-page":"10909","DOI":"10.4238\/2014.December.19.12","article-title":"Clinical study on gastric cancer susceptibility genes IL-10 -1082 and TNF \u03b1","volume":"13","author":"Yu","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.cyto.2018.04.017_b0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gene.2013.11.007","article-title":"Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population","volume":"10","author":"Qinghai","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.cyto.2018.04.017_b0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1155\/2012\/258293","article-title":"Association between IL17 polymorphisms and risk of cervical cancer in Chinese women","volume":"2012","author":"Quan","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cyto.2018.04.017_b0150","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.3748\/wjg.v19.i34.5693","article-title":"T, Polymorphism in the interleukin-17A promoter contributes to gastric cancer","volume":"19","author":"Rafiei","year":"2013","journal-title":"World. J. Gastroenterol."},{"key":"10.1016\/j.cyto.2018.04.017_b0155","doi-asserted-by":"crossref","first-page":"e86812","DOI":"10.1371\/journal.pone.0086812","article-title":"Tc17 cells in patients with uterine cervical cancer","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2018.04.017_b0160","doi-asserted-by":"crossref","first-page":"e0185168","DOI":"10.1371\/journal.pone.0185168","article-title":"The prognostic value of interleukin-17 in lung cancer: a systematic review with meta-analysis based on Chinese patients","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2018.04.017_b0165","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2008.12.033","article-title":"Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients","volume":"50","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2018.04.017_b0170","first-page":"348","article-title":"L'augmentation des cellules productrices d'IL-17 est corr\u00e9l\u00e9e avec une survie et une lymphangiogen\u00e8se m\u00e9diocres chez les patients atteints de CPNPC","volume":"69","author":"Chen","year":"2010","journal-title":"Cancer du Poumon"},{"key":"10.1016\/j.cyto.2018.04.017_b0175","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1245\/s10434-015-4923-3","article-title":"A high ROR\u03b3T\/CD3 ratio is a strong prognostic factor for postoperative survival in advanced colorectal cancer: analysis of helper T cell lymphocytes (Th1, Th2, Th17 and regulatory T cells)","volume":"23","author":"Yoshida","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.cyto.2018.04.017_b0180","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.humimm.2009.04.030","article-title":"Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis","volume":"70","author":"Shibata","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2018.04.017_b0185","doi-asserted-by":"crossref","first-page":"20439","DOI":"10.1038\/srep20439","article-title":"Role of IL-17A rs2275913 and IL-17F rs763780 polymorphisms in risk of cancer development: an updated meta-analysis","volume":"6","author":"Dai","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618301704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618301704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:50:21Z","timestamp":1760907021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618301704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":37,"alternative-id":["S1043466618301704"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.04.017","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of interleukin-17A polymorphisms with the risk of colorectal cancer: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}